Norges Bank Portfolio holdings
Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.
Top Buys
| 1 |
Apple
AAPL
|
$46.9B |
| 2 |
Microsoft
MSFT
|
$44.3B |
| 3 |
NVIDIA
NVDA
|
$43.5B |
| 4 |
Amazon
AMZN
|
$27.3B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$24.4B |
Top Sells
Sector Composition
| 1 | Technology | 31.08% |
| 2 | Financials | 14.18% |
| 3 | Consumer Discretionary | 11.56% |
| 4 | Healthcare | 10.01% |
| 5 | Communication Services | 9.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Prothena Corp
PRTA
$460M
| $796K | ﹤0.01% |
+57,454
| New | +$796K |
|
1777
Hilltop Holdings
HTH
$2.22B
| $789K | ﹤0.01% |
+27,573
| New | +$789K |
|
1778
Backblaze
BLZE
$491M
| $780K | ﹤0.01% |
+129,500
| New | +$780K |
|
1779
Kodiak Gas Services
KGS
$3.1B
| $766K | ﹤0.01% |
+18,763
| New | +$766K |
|
1780
Guess, Inc.
GES
$878M
| $765K | ﹤0.01% |
+54,426
| New | +$765K |
|
|
DAO
1781
Youdao
DAO
$1.04B
| $715K | ﹤0.01% |
+96,600
| New | +$715K |
|
|
CHCT
1782
Community Healthcare Trust
CHCT
$444M
| $678K | ﹤0.01% |
+35,300
| New | +$678K |
|
1783
DXP Enterprises
DXPE
$1.95B
| $669K | ﹤0.01% |
+8,100
| New | +$669K |
|
1784
Privia Health
PRVA
$2.86B
| $619K | ﹤0.01% |
+31,665
| New | +$619K |
|
1785
Douglas Dynamics
PLOW
$771M
| $617K | ﹤0.01% |
+26,100
| New | +$617K |
|
|
BRDG
1786
DELISTED
Bridge Investment Group
BRDG
| $597K | ﹤0.01% |
+71,100
| New | +$597K |
|
1787
MGP Ingredients
MGPI
$622M
| $571K | ﹤0.01% |
+14,504
| New | +$571K |
|
1788
Hackett Group
HCKT
$576M
| $565K | ﹤0.01% |
+18,400
| New | +$565K |
|
1789
Vanda Pharmaceuticals
VNDA
$272M
| $551K | ﹤0.01% |
+115,000
| New | +$551K |
|
|
ZBIO
1790
Zenas BioPharma, Inc. Common Stock
ZBIO
$864M
| $542K | ﹤0.01% |
+66,202
| New | +$542K |
|
1791
Werner Enterprises
WERN
$1.71B
| $539K | ﹤0.01% |
+15,005
| New | +$539K |
|
1792
Arcus Biosciences
RCUS
$1.3B
| $507K | ﹤0.01% |
+34,044
| New | +$507K |
|
1793
Sinclair Inc
SBGI
$964M
| $507K | ﹤0.01% |
+31,396
| New | +$507K |
|
1794
Treace Medical Concepts
TMCI
$453M
| $490K | ﹤0.01% |
+65,800
| New | +$490K |
|
|
RVNC
1795
DELISTED
Revance Therapeutics, Inc.
RVNC
| $489K | ﹤0.01% |
+161,000
| New | +$489K |
|
|
SHYF
1796
DELISTED
The Shyft Group
SHYF
| $464K | ﹤0.01% |
+39,500
| New | +$464K |
|
1797
Beam Therapeutics
BEAM
$2.11B
| $461K | ﹤0.01% |
+18,591
| New | +$461K |
|
|
MBX
1798
MBX Biosciences, Inc. Common Stock
MBX
$388M
| $461K | ﹤0.01% |
+25,000
| New | +$461K |
|
1799
Kenon Holdings
KEN
$2.32B
| $458K | ﹤0.01% |
+13,711
| New | +$458K |
|
|
VERV
1800
DELISTED
Verve Therapeutics
VERV
| $441K | ﹤0.01% |
+78,186
| New | +$441K |
|